.1AnnouncementsMay 15, 2025 Ada Welcoming Our New CRO: Steven K Fung Joins Iris.ai to Scale Real-World AI ImpactFor the past decade, we’ve built technology grounded in science, explainability, and real-world complexity. That technology is ready. Now it’s time to scale. We’re excited to welcome Steven K Fung as our new Chief Revenue Officer (CRO).
.2AnnouncementsDecember 19, 2024 Ada Announcement: New features in RSpace™ 1.3!We are excited to release the latest version of our platform, RSpace™ 1.3! Our team has been dedicated to enhancing your research experience, and we're thrilled to share the newest features and improvements with you.
.3Use CasesOctober 31, 2024 Ada Tomas Bata University and Iris.ai Collaboration: Driving Research Innovation with AIIn March 2024, Tomas Bata University in Zlín embarked on a transformative journey by acquiring a license for Iris.ai’s flagship AI-powered solution, RSpace™. As the first institution in the Czech Republic to integrate this cutting-edge tool, Tomas Bata University has taken a bold step towards enhancing the efficiency and innovation of its research practices.
.4AnnouncementsMay 30, 2024 Ada European scientific AI startup Iris.ai raises €7.64million with its Series A funding roundIris.ai, provider of a world-leading and award-winning AI engine for scientific text understanding, has announced its latest funding round, with an investment of €7.64m. This investment will support the company’s continued growth and innovation in the field of AI-assisted scientific research, and contribute to a dynamic European AI ecosystem.
.5Use CasesMay 23, 2024 Ada Transforming Pediatric Cancer Research with AI: A Collaboration Between Iris.ai and The Bardo FoundationThe Bardo Foundation, Iris.ai, and the European Innovation Council (EIC) have joined forces to revolutionize pediatric cancer research. This collaboration aims to integrate advanced AI technology into the research processes at Oslo University Hospital, with an initial focus on osteosarcoma. The partnership seeks to accelerate discoveries and enhance clinical outcomes for children battling rare cancers by making scientific literature and clinical data more accessible and navigable.